| Bioactivity | BIM 23056, a linear octapeptide, is a potent sst3 and sst5 somatostatin receptor antagonist with Ki values of 10.8, 5.7, respectively[1]. | ||||||
| Invitro | BIM 23056 has Ki values of 142, 16.6, >1000 for sst1, sst4, sst2 , respectively[1]. | ||||||
| Name | BIM-23056 | ||||||
| CAS | 150155-61-6 | ||||||
| Shortening | FFYWKVF-{D-2-Nal}-NH2 | ||||||
| Formula | C71H81N11O9 | ||||||
| Molar Mass | 1232.47 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
BIM-23056
CAS: 150155-61-6 F: C71H81N11O9 W: 1232.47
BIM 23056, a linear octapeptide, is a potent sst3 and sst5 somatostatin receptor antagonist with Ki values of 10.8, 5.7,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.